In 2024, France's share of scientific publications among the world’s top 10% cited in biotechnology is forecasted at 7.53%. The trend indicates a declining trajectory through 2028, reaching 6.01%. This represents a gradual decrease from 2023, where the share was higher. The year-on-year variation suggests a negative trend, with a consistent decline each year. The CAGR over the five-year period illustrates a notable decrease in France's standing.
Future trends to watch for include:
- Potential impacts of increased investment in biotechnology research.
- Collaborative efforts with international biotechnology hubs.
- Policy changes influencing research prioritization and funding.
- France's adaptability to emerging biotechnology innovations.
